| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunologic Deficiency Syndromes | 6 | 2021 | 201 | 0.780 |
Why?
|
| Blood Group Incompatibility | 2 | 2018 | 27 | 0.750 |
Why?
|
| ABO Blood-Group System | 2 | 2018 | 65 | 0.740 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 10 | 2023 | 1193 | 0.710 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2018 | 29 | 0.610 |
Why?
|
| Severe Combined Immunodeficiency | 3 | 2016 | 106 | 0.590 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 169 | 0.570 |
Why?
|
| Mutation | 8 | 2024 | 5794 | 0.550 |
Why?
|
| Rare Diseases | 3 | 2017 | 185 | 0.520 |
Why?
|
| Liver Transplantation | 3 | 2019 | 1034 | 0.500 |
Why?
|
| Granulomatous Disease, Chronic | 3 | 2020 | 65 | 0.490 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2018 | 3084 | 0.450 |
Why?
|
| Autoimmune Diseases | 3 | 2018 | 250 | 0.310 |
Why?
|
| Developmental Disabilities | 3 | 2023 | 695 | 0.310 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 21 | 0.300 |
Why?
|
| Heterozygote | 2 | 2022 | 682 | 0.300 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 145 | 0.290 |
Why?
|
| Protein Subunits | 1 | 2018 | 164 | 0.290 |
Why?
|
| Infant | 17 | 2023 | 12355 | 0.280 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 144 | 0.270 |
Why?
|
| Genome, Human | 2 | 2018 | 1261 | 0.270 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 130 | 0.270 |
Why?
|
| Child | 22 | 2023 | 24170 | 0.260 |
Why?
|
| Coatomer Protein | 2 | 2016 | 30 | 0.250 |
Why?
|
| Syndrome | 4 | 2023 | 1123 | 0.250 |
Why?
|
| Child, Preschool | 15 | 2023 | 13858 | 0.250 |
Why?
|
| Exome | 3 | 2022 | 1042 | 0.240 |
Why?
|
| Virus Diseases | 2 | 2019 | 280 | 0.240 |
Why?
|
| Alleles | 2 | 2018 | 1599 | 0.240 |
Why?
|
| Humans | 43 | 2024 | 122971 | 0.230 |
Why?
|
| Infant, Newborn | 9 | 2022 | 8120 | 0.230 |
Why?
|
| Ikaros Transcription Factor | 1 | 2023 | 28 | 0.220 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2023 | 47 | 0.210 |
Why?
|
| Male | 22 | 2024 | 59957 | 0.210 |
Why?
|
| Software | 1 | 2017 | 673 | 0.200 |
Why?
|
| Replication Protein A | 1 | 2022 | 11 | 0.200 |
Why?
|
| Genetic Variation | 2 | 2017 | 1476 | 0.200 |
Why?
|
| Mycobacterium bovis | 1 | 2022 | 35 | 0.200 |
Why?
|
| Hearing Loss | 1 | 2023 | 132 | 0.200 |
Why?
|
| Telomere Shortening | 1 | 2022 | 34 | 0.190 |
Why?
|
| Interferon Type I | 2 | 2021 | 107 | 0.190 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 469 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 553 | 0.190 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2021 | 8 | 0.190 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 104 | 0.190 |
Why?
|
| Craniofacial Abnormalities | 1 | 2023 | 243 | 0.190 |
Why?
|
| Afibrinogenemia | 1 | 2021 | 11 | 0.190 |
Why?
|
| Agammaglobulinemia | 1 | 2021 | 39 | 0.190 |
Why?
|
| Female | 22 | 2024 | 65361 | 0.180 |
Why?
|
| I-kappa B Kinase | 2 | 2022 | 61 | 0.180 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2022 | 137 | 0.180 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2017 | 789 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2021 | 140 | 0.180 |
Why?
|
| Telomere | 1 | 2022 | 205 | 0.180 |
Why?
|
| Fibrinogen | 1 | 2021 | 152 | 0.180 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2018 | 122 | 0.170 |
Why?
|
| Anaphylaxis | 1 | 2021 | 77 | 0.170 |
Why?
|
| Base Sequence | 2 | 2018 | 3118 | 0.160 |
Why?
|
| Hyper-IgM Immunodeficiency Syndrome | 1 | 2019 | 1 | 0.160 |
Why?
|
| Vaccines, Attenuated | 1 | 2019 | 173 | 0.160 |
Why?
|
| Graft Rejection | 2 | 2023 | 584 | 0.160 |
Why?
|
| Microcephaly | 1 | 2022 | 328 | 0.160 |
Why?
|
| Intellectual Disability | 2 | 2022 | 1043 | 0.160 |
Why?
|
| Hypersensitivity | 1 | 2021 | 182 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 1760 | 0.160 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2019 | 54 | 0.150 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 62 | 0.150 |
Why?
|
| Phenotype | 4 | 2018 | 4222 | 0.150 |
Why?
|
| Arthritis | 2 | 2016 | 80 | 0.150 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2017 | 22 | 0.150 |
Why?
|
| Alemtuzumab | 1 | 2018 | 88 | 0.150 |
Why?
|
| Mutant Proteins | 1 | 2018 | 112 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 558 | 0.150 |
Why?
|
| Chromatin | 1 | 2021 | 553 | 0.150 |
Why?
|
| Immunosuppressive Agents | 2 | 2019 | 646 | 0.150 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 175 | 0.140 |
Why?
|
| Postoperative Care | 1 | 2019 | 292 | 0.140 |
Why?
|
| Immunophenotyping | 1 | 2018 | 332 | 0.140 |
Why?
|
| Paramyxoviridae Infections | 1 | 2017 | 44 | 0.140 |
Why?
|
| Organ Transplantation | 1 | 2019 | 163 | 0.140 |
Why?
|
| Clinical Protocols | 1 | 2018 | 237 | 0.140 |
Why?
|
| Metapneumovirus | 1 | 2017 | 51 | 0.140 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2022 | 383 | 0.140 |
Why?
|
| Adolescent | 13 | 2022 | 19043 | 0.140 |
Why?
|
| Trans-Activators | 1 | 2021 | 805 | 0.140 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 501 | 0.140 |
Why?
|
| Postoperative Complications | 2 | 2019 | 3002 | 0.140 |
Why?
|
| Autism Spectrum Disorder | 1 | 2022 | 374 | 0.140 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 279 | 0.140 |
Why?
|
| Cell Line | 2 | 2021 | 2787 | 0.140 |
Why?
|
| Transcription Factors | 1 | 2016 | 2589 | 0.140 |
Why?
|
| Genetic Association Studies | 2 | 2017 | 759 | 0.140 |
Why?
|
| Heart Transplantation | 1 | 2023 | 854 | 0.140 |
Why?
|
| Young Adult | 9 | 2023 | 8830 | 0.140 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 149 | 0.130 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2016 | 9 | 0.130 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2016 | 26 | 0.130 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 547 | 0.130 |
Why?
|
| Transplantation Conditioning | 1 | 2017 | 323 | 0.130 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 865 | 0.130 |
Why?
|
| Immunization, Passive | 1 | 2016 | 119 | 0.130 |
Why?
|
| Autoimmunity | 2 | 2019 | 172 | 0.130 |
Why?
|
| Exons | 1 | 2018 | 795 | 0.130 |
Why?
|
| Tuberculosis | 1 | 2022 | 570 | 0.130 |
Why?
|
| Enteritis | 1 | 2016 | 55 | 0.120 |
Why?
|
| Dendritic Cells | 2 | 2021 | 405 | 0.120 |
Why?
|
| Golgi Apparatus | 1 | 2015 | 92 | 0.120 |
Why?
|
| Family | 1 | 2018 | 572 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 5025 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1151 | 0.120 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 1679 | 0.120 |
Why?
|
| Inflammation | 2 | 2019 | 1401 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2018 | 2833 | 0.110 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 178 | 0.110 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 147 | 0.110 |
Why?
|
| Skin Diseases | 1 | 2014 | 122 | 0.110 |
Why?
|
| Treatment Outcome | 5 | 2024 | 12083 | 0.110 |
Why?
|
| Caliciviridae Infections | 1 | 2016 | 315 | 0.100 |
Why?
|
| Cytokines | 2 | 2021 | 1287 | 0.100 |
Why?
|
| Chemokines | 1 | 2012 | 137 | 0.100 |
Why?
|
| Killer Cells, Natural | 1 | 2014 | 323 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2018 | 995 | 0.100 |
Why?
|
| Immunoglobulins | 2 | 2024 | 170 | 0.090 |
Why?
|
| DiGeorge Syndrome | 1 | 2011 | 80 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 280 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 217 | 0.090 |
Why?
|
| Adult | 9 | 2023 | 28944 | 0.090 |
Why?
|
| Delayed Diagnosis | 1 | 2011 | 121 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2023 | 15934 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2012 | 328 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2018 | 2702 | 0.080 |
Why?
|
| Enterobacteriaceae | 1 | 2008 | 35 | 0.070 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2008 | 55 | 0.070 |
Why?
|
| Genitalia | 1 | 2016 | 35 | 0.070 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 143 | 0.070 |
Why?
|
| Genotype | 2 | 2017 | 2536 | 0.070 |
Why?
|
| Biopsy | 2 | 2023 | 1256 | 0.070 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 101 | 0.070 |
Why?
|
| Speech Disorders | 1 | 2016 | 42 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 131 | 0.070 |
Why?
|
| Zinc Fingers | 1 | 2016 | 114 | 0.070 |
Why?
|
| Whole Genome Sequencing | 2 | 2018 | 285 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2021 | 745 | 0.060 |
Why?
|
| Muscle Hypotonia | 1 | 2016 | 186 | 0.060 |
Why?
|
| Education, Professional | 1 | 2005 | 10 | 0.060 |
Why?
|
| Community Networks | 1 | 2005 | 33 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2016 | 255 | 0.060 |
Why?
|
| Ataxia | 1 | 2016 | 168 | 0.060 |
Why?
|
| Information Dissemination | 1 | 2017 | 186 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2017 | 469 | 0.060 |
Why?
|
| Cross Infection | 1 | 2008 | 332 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1936 | 0.060 |
Why?
|
| Qualitative Research | 1 | 2017 | 519 | 0.060 |
Why?
|
| Lung Diseases | 2 | 2019 | 385 | 0.060 |
Why?
|
| Metabolomics | 1 | 2017 | 396 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 1229 | 0.050 |
Why?
|
| Busulfan | 1 | 2023 | 44 | 0.050 |
Why?
|
| Erythrocyte Count | 1 | 2003 | 21 | 0.050 |
Why?
|
| Mitochondria | 1 | 2018 | 684 | 0.050 |
Why?
|
| Spinal Puncture | 1 | 2003 | 53 | 0.050 |
Why?
|
| Transposases | 1 | 2022 | 40 | 0.050 |
Why?
|
| Survival Rate | 2 | 2017 | 1999 | 0.050 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2021 | 10 | 0.050 |
Why?
|
| Lymphopoiesis | 1 | 2021 | 10 | 0.050 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2021 | 13 | 0.050 |
Why?
|
| BCG Vaccine | 1 | 2022 | 115 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 422 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2005 | 431 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 973 | 0.040 |
Why?
|
| Health Personnel | 1 | 2005 | 500 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 248 | 0.040 |
Why?
|
| Spinal Cord Injuries | 1 | 2003 | 311 | 0.040 |
Why?
|
| Genomics | 2 | 2018 | 1472 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2021 | 220 | 0.040 |
Why?
|
| Middle Aged | 4 | 2022 | 25885 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2023 | 634 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 520 | 0.040 |
Why?
|
| Chimerism | 1 | 2018 | 28 | 0.040 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2018 | 28 | 0.040 |
Why?
|
| Pancytopenia | 1 | 2018 | 40 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 317 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2019 | 359 | 0.040 |
Why?
|
| Unrelated Donors | 1 | 2018 | 82 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 799 | 0.040 |
Why?
|
| Granzymes | 1 | 2017 | 39 | 0.040 |
Why?
|
| Immunodominant Epitopes | 1 | 2017 | 50 | 0.040 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 68 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 138 | 0.040 |
Why?
|
| Allografts | 1 | 2017 | 190 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 541 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 204 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 1247 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 1007 | 0.030 |
Why?
|
| Sepsis | 1 | 2020 | 479 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 326 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 60 | 0.030 |
Why?
|
| Stem Cells | 1 | 2021 | 713 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2018 | 4688 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 868 | 0.030 |
Why?
|
| Duodenum | 1 | 2016 | 99 | 0.030 |
Why?
|
| Lod Score | 1 | 2015 | 120 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 301 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 512 | 0.030 |
Why?
|
| Incidence | 2 | 2018 | 3040 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 2060 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 672 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 756 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 213 | 0.030 |
Why?
|
| Viral Load | 1 | 2016 | 384 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 369 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 446 | 0.030 |
Why?
|
| Prevalence | 2 | 2011 | 2390 | 0.030 |
Why?
|
| Aminosalicylic Acids | 1 | 2012 | 1 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1006 | 0.030 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 11 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 48 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6020 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 1301 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2016 | 479 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 2016 | 543 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4503 | 0.020 |
Why?
|
| United States | 1 | 2017 | 10564 | 0.020 |
Why?
|
| Pedigree | 1 | 2015 | 1580 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 942 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 292 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 1073 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 1635 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 664 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 516 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 1106 | 0.020 |
Why?
|
| Pediatrics | 1 | 2019 | 1142 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3888 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 1302 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 2799 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2584 | 0.020 |
Why?
|
| District of Columbia | 1 | 2008 | 14 | 0.020 |
Why?
|
| Sentinel Surveillance | 1 | 2008 | 19 | 0.020 |
Why?
|
| Intensive Care, Neonatal | 1 | 2008 | 54 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2008 | 156 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 2396 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2008 | 148 | 0.020 |
Why?
|
| Infection Control | 1 | 2008 | 160 | 0.020 |
Why?
|
| Commonwealth of Independent States | 1 | 2005 | 1 | 0.020 |
Why?
|
| International Agencies | 1 | 2005 | 28 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 1598 | 0.010 |
Why?
|
| Schools | 1 | 2005 | 210 | 0.010 |
Why?
|
| Emergency Medicine | 1 | 2005 | 154 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 9950 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2008 | 779 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 2003 | 93 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2005 | 263 | 0.010 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2003 | 73 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 4524 | 0.010 |
Why?
|
| Curriculum | 1 | 2005 | 718 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 18998 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2003 | 1067 | 0.010 |
Why?
|